Relief Therapeutics Holding AG (RLFTF)

[Andy2018]

What ever data Presented to FDA was 100% patients recovered. Randomized double blinded placebo control studies going on and DMC reviewing interim data we will likely hear from DMC soon they might ask $RLFTF to halt and request FDA to accelerate approval to treat all critical patients since its unethical to continue keeping patients in placebo group if efficacy is promising.